| Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis J Yang, YA Zheng, X Gou, K Pu, Z Chen, Q Guo, R Ji, H Wang, Y Wang, ... International journal of infectious diseases 94, 91-95, 2020 | 3808 | 2020 |
| COVID‐19 patients' clinical characteristics, discharge rate, and fatality rate of meta‐analysis L Li, T Huang, Y Wang, Z Wang, Y Liang, T Huang, H Zhang, W Sun, ... Journal of medical virology 92 (6), 577-583, 2020 | 1804 | 2020 |
| Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling J Huang, DL Zheng, FS Qin, N Cheng, H Chen, BB Wan, YP Wang, ... The Journal of clinical investigation 120 (1), 223-241, 2010 | 162 | 2010 |
| Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta … K Pu, Y Wang, S Bai, H Wei, Y Zhou, J Fan, L Qiao BMC gastroenterology 19, 1-11, 2019 | 161 | 2019 |
| Advances in the techniques and methodologies of cancer gene therapy W Sun, Q Shi, H Zhang, K Yang, Y Ke, Y Wang, L Qiao Discovery medicine 27 (146), 45-55, 2019 | 117 | 2019 |
| Stem cells in gastric cancer Y Zhao, F Feng, YN Zhou World journal of gastroenterology: WJG 21 (1), 112, 2015 | 78 | 2015 |
| COX-2 regulates E-cadherin expression through the NF-κB/Snail signaling pathway in gastric cancer Corrigendum in/10.3892/ijmm. 2022.5083 Z Chen, MIN Liu, X Liu, S Huang, L Li, BO Song, H Li, Q Ren, Z Hu, ... International journal of molecular medicine 32 (1), 93-100, 2013 | 70 | 2013 |
| Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer Z Chen, X Liu, Z Hu, Y Wang, M Liu, X Liu, H Li, R Ji, Q Guo, Y Zhou Oncology letters 10 (1), 329-336, 2015 | 55 | 2015 |
| SRPK1 contributes to malignancy of hepatocellular carcinoma through a possible mechanism involving PI3K/Akt B Zhou, Y Li, Q Deng, H Wang, Y Wang, B Cai, ZG Han Molecular and cellular biochemistry 379, 191-199, 2013 | 51 | 2013 |
| A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients: a … Q Guo, Q Li, J Wang, M Liu, Y Wang, Z Chen, Y Ye, Q Guan, Y Zhou Medicine 98 (27), e16234, 2019 | 44 | 2019 |
| Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma YP Wang, LY Huang, WM Sun, ZZ Zhang, JZ Fang, BF Wei, BH Wu, ... Cancer letters 337 (1), 96-106, 2013 | 41 | 2013 |
| Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes HL Li, SP Xie, YL Yang, YX Cheng, Y Zhang, J Wang, Y Wang, DL Liu, ... Asian Pacific journal of cancer prevention 16 (5), 1781-1787, 2015 | 36 | 2015 |
| Possible regulatory role of Snail in NF-κB-mediated changes in E-cadherin in gastric cancer Z Hu, X Liu, Z Tang, Y Zhou, L Qiao Oncology Reports 29 (3), 993-1000, 2013 | 36 | 2013 |
| Prevalence and associated risk factors of Helicobacter pylori infection in the Wuwei cohort of north‐western China F Zhang, K Pu, Z Wu, Z Zhang, X Liu, Z Chen, Y Ye, Y Wang, Y Zheng, ... Tropical Medicine & International Health 26 (3), 290-300, 2021 | 35 | 2021 |
| ALDH1A1 in cancers: bidirectional function, drug resistance, and regulatory mechanism H Yue, Z Hu, R Hu, Z Guo, Y Zheng, Y Wang, Y Zhou Frontiers in oncology 12, 918778, 2022 | 34 | 2022 |
| Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer H Yuan, Z Chen, S Bai, H Wei, Y Wang, R Ji, Q Guo, Q Li, Y Ye, J Wu, ... Cancer Letters 418, 84-96, 2018 | 34 | 2018 |
| Embelin and its role in chronic diseases H Lu, J Wang, Y Wang, L Qiao, Y Zhou Anti-inflammatory Nutraceuticals and Chronic Diseases, 397-418, 2016 | 33 | 2016 |
| Prognostic role of tumor mutational burden in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis T Huang, X Chen, H Zhang, Y Liang, L Li, H Wei, W Sun, Y Wang Frontiers in oncology 11, 706652, 2021 | 30 | 2021 |
| The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta‑analysis H Wei, K Pu, XG Liu, BX Li, HS Zhang, H Wang, H Wang, WM Sun, ... Oncology reports 41 (1), 87-102, 2019 | 30 | 2019 |
| Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells XJ Liu, ZF Chen, HL Li, ZN Hu, M Liu, AP Tian, D Zhao, J Wu, YN Zhou, ... World Journal of Gastroenterology: WJG 19 (37), 6265, 2013 | 29 | 2013 |
Liang QiaoThe University of SydneyVerified email at sydney.edu.au
